217 related articles for article (PubMed ID: 32946466)
81. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy.
Zangrillo A; Beretta L; Scandroglio AM; Monti G; Fominskiy E; Colombo S; Morselli F; Belletti A; Silvani P; Crivellari M; Monaco F; Azzolini ML; Reineke R; Nardelli P; Sartorelli M; Votta CD; Ruggeri A; Ciceri F; De Cobelli F; Tresoldi M; Dagna L; Rovere-Querini P; Serpa Neto A; Bellomo R; Landoni G;
Crit Care Resusc; 2020 Sep; 22(3):200-211. PubMed ID: 32900326
[TBL] [Abstract][Full Text] [Related]
82. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
83. Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Roehrig S; Ait Hssain A; Shallik NAH; Elsaid IMA; Mustafa SF; Smain OAM; Molokhia AA; Lance MD
Trials; 2020 Sep; 21(1):781. PubMed ID: 32917259
[TBL] [Abstract][Full Text] [Related]
84. The effect of surfactant on clinical outcome of patients with COVID-19 under mechanical ventilation: A structured summary of a study protocol for a randomised controlled trial.
Dabbagh A; Rajaei S; Ghahremani M; Fathi M; Massoudi N; Tavana S; Fani K; Nooraee N; Malekpour Alamdari N; Besharat S; Najafi Abrandabadi A; Pirsalehi A; Khabiri Khatiri MA
Trials; 2020 Nov; 21(1):919. PubMed ID: 33176850
[TBL] [Abstract][Full Text] [Related]
85. The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Johansson PI; Bestle M; Søe-Jensen P; Kristiansen KT; Stensballe J; Clausen NE; Perner A
Trials; 2020 Aug; 21(1):746. PubMed ID: 32847626
[TBL] [Abstract][Full Text] [Related]
86. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
Lippi G; Plebani M
Clin Chim Acta; 2020 Jun; 505():190-191. PubMed ID: 32145275
[No Abstract] [Full Text] [Related]
87. Characteristics, laboratories, and prognosis of severe COVID-19 in the Tokyo metropolitan area: A retrospective case series.
Mori S; Ai T; Otomo Y
PLoS One; 2020; 15(9):e0239644. PubMed ID: 32970757
[TBL] [Abstract][Full Text] [Related]
88. Intensive Care Unit Admissions During the First 3 Months of the COVID-19 Pandemic in Poland: A Single-Center, Cross-Sectional Study.
Kokoszka-Bargieł I; Cyprys P; Rutkowska K; Madowicz J; Knapik P
Med Sci Monit; 2020 Sep; 26():e926974. PubMed ID: 32979262
[TBL] [Abstract][Full Text] [Related]
89. CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation.
Ashish A; Unsworth A; Martindale J; Sundar R; Kavuri K; Sedda L; Farrier M
BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33148777
[TBL] [Abstract][Full Text] [Related]
90. Safety and efficacy of tocilizumab in the treatment of severe acute respiratory syndrome coronavirus-2 pneumonia: A retrospective cohort study.
Patel A; Shah K; Dharsandiya M; Patel K; Patel T; Patel M; Reljic T; Kumar A
Indian J Med Microbiol; 2020; 38(1):117-123. PubMed ID: 32719218
[TBL] [Abstract][Full Text] [Related]
91. Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury.
Si D; Du B; Ni L; Yang B; Sun H; Jiang N; Liu G; Massé S; Jin L; Nanthakumar J; Bhaskaran A; Yang P; Nanthakumar K
CMAJ; 2020 Jul; 192(28):E791-E798. PubMed ID: 32586839
[TBL] [Abstract][Full Text] [Related]
92. Lung ultrasound predicts clinical course and outcomes in COVID-19 patients.
Lichter Y; Topilsky Y; Taieb P; Banai A; Hochstadt A; Merdler I; Gal Oz A; Vine J; Goren O; Cohen B; Sapir O; Granot Y; Mann T; Friedman S; Angel Y; Adi N; Laufer-Perl M; Ingbir M; Arbel Y; Matot I; Szekely Y
Intensive Care Med; 2020 Oct; 46(10):1873-1883. PubMed ID: 32860069
[TBL] [Abstract][Full Text] [Related]
93. Characteristics and outcomes of patients infected with nCoV19 requiring invasive mechanical ventilation in Argentina.
Plotnikow GA; Matesa A; Nadur JM; Alonso M; Nuñez I I; Vergara G; Alfageme MJ; Vitale A; Gil M; Kinzler V; Melia M; Pugliese F; Donnianni M; Pochettino J; Brozzi I; Scapellato JL;
Rev Bras Ter Intensiva; 2020; 32(3):348-353. PubMed ID: 33053023
[TBL] [Abstract][Full Text] [Related]
94. Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalization.
Chachkhiani D; Soliman MY; Barua D; Isakadze M; Villemarette-Pittman NR; Devier DJ; Lovera JF
Clin Neurol Neurosurg; 2020 Oct; 197():106173. PubMed ID: 32877769
[TBL] [Abstract][Full Text] [Related]
95. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
96. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
97. Pediatric patients with COVID-19 admitted to intensive care units in Brazil: a prospective multicenter study.
Prata-Barbosa A; Lima-Setta F; Santos GRD; Lanziotti VS; de Castro REV; de Souza DC; Raymundo CE; de Oliveira FRC; de Lima LFP; Tonial CT; Colleti J; Bellinat APN; Lorenzo VB; Zeitel RS; Pulcheri L; Costa FCMD; La Torre FPF; Figueiredo EADN; Silva TPD; Riveiro PM; Mota ICFD; Brandão IB; de Azevedo ZMA; Gregory SC; Boedo FRO; de Carvalho RN; Castro NAASR; Genu DHS; Foronda FAK; Cunha AJLA; de Magalhães-Barbosa MC;
J Pediatr (Rio J); 2020; 96(5):582-592. PubMed ID: 32781034
[TBL] [Abstract][Full Text] [Related]
98. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
Richardson S; Hirsch JS; Narasimhan M; Crawford JM; McGinn T; Davidson KW; ; Barnaby DP; Becker LB; Chelico JD; Cohen SL; Cookingham J; Coppa K; Diefenbach MA; Dominello AJ; Duer-Hefele J; Falzon L; Gitlin J; Hajizadeh N; Harvin TG; Hirschwerk DA; Kim EJ; Kozel ZM; Marrast LM; Mogavero JN; Osorio GA; Qiu M; Zanos TP
JAMA; 2020 May; 323(20):2052-2059. PubMed ID: 32320003
[TBL] [Abstract][Full Text] [Related]
99. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study.
Yang X; Cai S; Luo Y; Zhu F; Hu M; Zhao Y; Zheng R; Li X; Hu B; Peng Z
Crit Care Med; 2020 Sep; 48(9):1289-1295. PubMed ID: 32427613
[TBL] [Abstract][Full Text] [Related]
100. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
Pereira MFB; Litvinov N; Farhat SCL; Eisencraft AP; Gibelli MABC; Carvalho WB; Fernandes VR; Fink TT; Framil JVS; Galleti KV; Fante AL; Fonseca MFM; Watanabe A; Paula CSY; Palandri GG; Leal GN; Diniz MFR; Pinho JRR; Silva CA; Marques HHS; ; Rossi Junior A; Delgado AF; Andrade APM; Schvartsman C; Sabino EC; Rocha MC; Kanunfre KA; Okay TS; Carneiro-Sampaio MMS; Jorge PPD
Clinics (Sao Paulo); 2020; 75():e2209. PubMed ID: 32844958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
